The Rare Disease Business Manager (RDBM) drives sales and territory growth through execution of sales strategies and tactics for narcolepsy type 1 (NT1), a rare neurological sleep disorder. The role collaborates with a Regional Business Leader and cross-functional, customer-facing teams to educate healthcare providers and support appropriate patient access to a new therapeutic option, once approved by federal agencies. The RDBM supports a new product introduction in a new therapeutic area for Takeda. The role builds impactful relationships with targeted healthcare providers and accounts in the assigned geographic territory, gathers insights, and helps build the company’s reputation. Following regulatory approval, the RDBM educates and informs healthcare professionals by providing clinical information and in-depth knowledge of the product, the orexin system, and NT1, and generates demand for the therapy. The position executes sales and marketing plans using approved, on-label materials; manages territory activities and budget; analyzes market trends and opportunities; and works with Patient Access, Market Access, Marketing, and Sales leadership to align tactics and improve customer and business outcomes. The RDBM is expected to uphold Takeda’s compliance policies, applicable laws and regulations, and patient-first values.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level